Cannabis Not Recommended to Prevent Post-op Nausea

This article originally appeared here.
Share this content:
Cannabis Not Recommended to Prevent Post-op Nausea
Cannabis Not Recommended to Prevent Post-op Nausea

WEDNESDAY, Oct. 14, 2015 (HealthDay News) -- Cannabis should not be used to prevent postoperative nausea and vomiting (PONV) because of unacceptable side effects and low effectiveness, according to a study published online Sept. 30 in Anesthesia & Analgesia.

Maren Kleine-Brueggeney, M.D., from the University of Bern in Switzerland, and colleagues randomized 40 patients at high risk for PONV to either 0.125 mg/kg intravenous tetrahydrocannabinol (THC) or placebo at the end of surgery before emergence from anesthesia.

The researchers found that the relative risk reduction of overall PONV in the THC group was 12 percent, lower than the clinically significant 25 percent relative risk reduction demonstrated by other drugs used for PONV prophylaxis. After the researchers adjusted for anesthesia time, the effect of treatment had an odds ratio of 0.97 (P = 0.97). There were clinically relevant psychotropic THC side effects, mainly consisting of sedation and confusion not related to the effects of anesthesia. The study was discontinued because of THC's inefficacy and the clinically unacceptable side effects.

"Because of an unacceptable side effect profile and uncertain antiemetic effects, IV THC administered at the end of surgery before emergence from anesthesia cannot be recommended for the prevention of PONV in high-risk patients," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Global Prevalence of Insufficient Activity 27.5 Percent

Global Prevalence of Insufficient Activity 27.5 Percent

Levels of insufficient physical activity stable between 2001, 2016; increase seen in high-income countries

HTN Tx Intensification Common Upon Discharge in U.S. Vets

HTN Tx Intensification Common Upon Discharge in U.S. ...

Fourteen percent of older adults admitted to hospital for non-cardiac conditions had intensification of tx

Quarterly Canakinumab Reduces Risk for Gout Attacks

Quarterly Canakinumab Reduces Risk for Gout Attacks

Doesn't affect serum uric acid levels over time, but targets interleukin-1β

is free, fast, and customized just for you!




Already a member?

Sign In Now »